NDC 50242-061

Avastin

Bevacizumab

Avastin is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Bevacizumab.

• Product ID: 50242-061_3580958a-7a01-45c0-8d9c-87d9a3963158
• NDC: 50242-061
• Product Type: Human Prescription Drug
• Proprietary Name: Avastin
• Generic Name: Bevacizumab
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2004-02-26
• Marketing Category: BLA / BLA
• Application Number: BLA125085
• Labeler Name: Genentech, Inc.
• Substance Name: BEVACIZUMAB
• Active Ingredient Strength: 400 mg/16mL
• Pharm Classes: Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 50242-061-01

1 VIAL, SINGLE-USE in 1 CARTON (50242-061-01) > 16 mL in 1 VIAL, SINGLE-USE

• Marketing Start Date: 2004-02-26
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 50242-061-10 [50242006110]

Avastin INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA125085
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2019-04-01

NDC 50242-061-01 [50242006101]

Avastin INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA125085
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2004-02-26

Drug Details

Active Ingredients

Ingredient	Strength
BEVACIZUMAB	400 mg/16mL

OpenFDA Data

• SPL SET ID: 939b5d1f-9fb2-4499-80ef-0607aa6b114e
• Manufacturer:
  • Genentech, Inc.
• UNII:
  • 2S9ZZM9Q9V
• RxNorm Concept Unique ID - RxCUI:
  • 1657074
  • 1657068
  • 1657066
  • 1657073

Pharmacological Class

• Vascular Endothelial Growth Factor Inhibitor [EPC]
• Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
• Vascular Endothelial Growth Factor Inhibitors [MoA]

NDC Crossover Matching brand name "Avastin" or generic name "Bevacizumab"

NDC	Brand Name	Generic Name
50242-060	Avastin	bevacizumab
50242-061	Avastin	bevacizumab